Discovery of a neuroendocrine tumor of the caecum by mammary metastasis using 18F-DOPA-PET

被引:2
作者
Gornes, Hugo [1 ]
Vaysse, Charlotte [1 ]
Deslandres, Marion [2 ]
Perallon, Romain [3 ]
Chantalat, Elodie [1 ]
Rimailho, Jacques [1 ]
机构
[1] Ctr Hosp Univ Rangueil, Inst Univ Canc Toulouse, Chirurg Gen & Gynecol, Toulouse, France
[2] Ctr Hosp Univ Rangueil, Inst Univ Canc Toulouse, Serv Oncol, Toulouse, France
[3] Inst Univ Canc Toulouse Oncopole, Inst Claudius Regaud, Serv Anatomopathol, Toulouse, France
关键词
18F-DOPA-PET; breast; caecum; mammary metastasis; neuroendocrine tumor; octreoscan; ENDOCRINE; CDX-2; TTF-1; PDX-1;
D O I
10.1111/jog.13776
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Neuroendocrine tumors (NET) develop from the diffuse endocrine system. These are rare tumors that can affect diverse organs. We present here the case of a 42-year-old female patient in whom a NET of the breast was discovered that was likely not of mammary origin. The main challenge was finding the primary tumor using immunohistochemistry and specific medical imaging modalities for NET. The primary tumor was localized at the last ileal loop upstream of the Bauhin valve thanks to the use of 18F-DOPA-PET. Ileocaecal resection by laparoscopy was performed. A WHO grade 2 NET of the ileum measuring 2.2 cm x 1.5 cm was found that infiltrated the submucosa with six metastatic lymph nodes of the eight removed (6N+/8). This unusual clinical case is the first one of a digestive NET of the ileum-caecal junction by mammary metastasis.
引用
收藏
页码:2195 / 2198
页数:4
相关论文
共 15 条
[1]   Performance of 18Fluorodeoxyglucose-Positron Emission Tomography and Somatostatin Receptor Scintigraphy for High Ki67 (≥10%) Well-Differentiated Endocrine Carcinoma Staging [J].
Abgral, Ronan ;
Leboulleux, Sophie ;
Deandreis, Desiree ;
Auperin, Anne ;
Lumbroso, Jean ;
Dromain, Clarisse ;
Duvillard, Pierre ;
Elias, Dominique ;
de Baere, Thierry ;
Guigay, Joel ;
Ducreux, Michel ;
Schlumberger, Martin ;
Baudin, Eric .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (03) :665-671
[2]  
Al-Maghrabi JA, 2012, SAUDI MED J, V33, P676
[3]  
Amin AL, 2011, PAN AFR MED J, V110, P140
[4]  
Amin Amanda L, 2011, WMJ, V110, P140
[5]   PDX-1, CDX-2, TTF-1, and CK7: A Reliable Immunohistochemical Panel for Pancreatic Neuroendocrine Neoplasms [J].
Chan, Elaine S. ;
Alexander, Jacob ;
Swanson, Paul E. ;
Jain, Dhanpat ;
Yeh, Matthew M. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (05) :737-743
[6]   Cdx2 as a marker for neuroendocrine tumors of unknown primary sites [J].
Erickson, LA ;
Papouchado, B ;
Dimashkieh, H ;
Zhang, SY ;
Nakamura, N ;
Lloyd, RV .
ENDOCRINE PATHOLOGY, 2004, 15 (03) :247-252
[7]   68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors:: Comparison with somatostatin receptor scintigraphy and CT [J].
Gabriel, Michael ;
Decristoforo, Clemens ;
Kendler, Dorota ;
Dobrozemsky, Georg ;
Heute, Dirk ;
Uprimny, Christian ;
Kovacs, Peter ;
Von Guggenberg, Elisabeth ;
Bale, Reto ;
Virgolini, Irene J. .
JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (04) :508-518
[8]   Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours [J].
Kaltsas, G ;
Rockall, A ;
Papadogias, D ;
Reznek, R ;
Grossman, AB .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 151 (01) :15-27
[9]  
Malherbe C, 2017, MED NUCL, V41, P184, DOI [10. 1016/j. mednuc. 2017. 02. 124, DOI 10.1016/J.MEDNUC.2017.02.124]
[10]   Cdx2 protein expression in normal and malignant human tissues: An immunohistochemical survey using tissue microarrays [J].
Moskaluk, CA ;
Zhang, H ;
Powell, SM ;
Cerilli, LA ;
Hampton, GM ;
Frierson, HF .
MODERN PATHOLOGY, 2003, 16 (09) :913-919